Table 1.
Baseline characteristics of cohort studies included.
| First Author | Publication Date | Country | Sample size | Disease Type | Intervention | Antibiotic | Outcomes | Factors for Multivariate Analysis |
|---|---|---|---|---|---|---|---|---|
| Mariangela Allocca (19) | 2020 Oct | Italy | 41 | 29%UC, 22%CD, 20%PS, 10%PsA, 12%RA, 2%AS, 2%SSc, 2%SLE,1%others | 7CS, 10IM, 28BIO | NA | hospitalizaiton, oxygen need, death, | age, gender, medication, comorbidities, rheumatic disease diagnosis |
| Milena Gianfrancesco (20) | 2020 May | Multi-national | 600 | 38%RA, 14%SLE, 12%PsA, 8%AS, 7%vasculitis, 5%SS, 3%SSc, 10%others | 32CS | NA | hospitalizaiton, death, | age, gender, rheumatic disease diagnosis, comorbidities, medication |
| Anja Strangfeld (21) | 2021 Jan | Multi-national | 3279 | 36.7%RA, 12.5%AS, 12.6%PsA, 10.6%SLE, 7.7%vasculitis, 19.9%others | 1056CS, 1267DMARD, 296IM, 1310BIO | NA | death | age, gender, rheumatic disease diagnosis, comorbidities, medication |
| FAIR/SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors (22) | 2021 Apr | France | 694 | 30.7%RA, 23.8%AS, 10.1%PsA, 9.3%vasculitis,6.6%SLE, 3.6%SSc, 2.5%SS, 13.5%others | 215CS, 328IM,354BIO | NA | moderate:hospitalization, severe:ICU or death | age, gender, diagnosis, medications, comorbidities |
| Jesse Veenstra (23) | 2020 Dec | USA | 77 | 33.8%RA/AS, 13.6%PS/PsA, 17.8%IBD, 15.5%SLE/DM/PM/MCTD/ILD/Scl | 12CS, 41IM, 30BIO | NA | hospitalization,ventilator | NA |
| Rebecca Haberman (24) | 2020 Apr | USA | 86 | 16%PS, 24%PsA, 23%RA, 20%UC, 23%CD, 10%AS | 62BIO,17MTX, 8CS | NA | hospitalizaiton, oxygen need, ICU, death, | age,sex,comorbidities,BMI,medication |
| Mariangela Allocca (25) | 2020 Nov | Multi-national | 97 | 44%UC,55%CD, 1% IBD-U | 8CS,24IM,51BIO, | NA | hospitalization, ICU, death | age, gender, comorbidities, diagnosis, medication |
| Claudia Diniz Lopes Marques (26) | 2021 Jan | Brasil | 334 | 32.9%SLE, 28.4%RA, 13.5%AS, 6.9%SSc, 6.9%PsA, 3.3%vasculitis, 8.3%others | 234CS, 154IM,116BIO | NA | hospitalization, ICU, ventilation, death | age, diagnosis, medication, comorbidities |
UC, ulcerative colitis; CD, Crohn’s disease; IBD-U, inflammatory bowel disease-unclassified; PS, psoriasis; PsA psoriatic arthritis; RA, rheumatoid arthritis; AS, ankylosing spondylitis; SLE, Systemic lupus erythematosus; SS, Sjogren’s syndrome; SSc, systemic sclerosis; DM, dermatomyositis; PM, polymyositis; MCTD, mixed connective tissue disease; ILD, interstitial lung disease; CS, corticosteroids; IM, immunocmodulators; BIO, biologics; DMARD, disease-modifying antirheumatic drug; MTX, methotrexate.